Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

AQST holding history

Aquestive Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AQST overviewAll 13F holders of AQSTFull Q2 2026 holdings

Shares (Q2 2026)
106,175
Value
$441.7K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of AQST by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026106,175$441.7K<0.1%+1,523+1.5%AddedHolders
Q1 2026104,652$434.3K<0.1%+13,112+14.3%AddedHolders
Q4 202591,540$591.3K<0.1%−9,498−9.4%ReducedHolders
Q3 2025101,038$564.8K<0.1%+1,425+1.4%AddedHolders
Q2 202599,613$329.7K<0.1%−9,050−8.3%ReducedHolders
Q1 2025108,663$315.1K<0.1%+29,027+36.4%AddedHolders
Q4 202479,636$283.5K<0.1%−28,377−26.3%ReducedHolders
Q3 2024108,013$537.0K<0.1%−200−0.2%ReducedHolders
Q2 2024108,213$282.0K<0.1%+108,213NewHolders
Q1 20240$00.0%−130,805−100.0%Sold outHolders
Q4 2023130,805$265.0K<0.1%+500+0.4%AddedHolders
Q3 2023130,305$199.0K<0.1%00.0%UnchangedHolders
Q2 2023130,305$216.0K<0.1%00.0%UnchangedHolders
Q1 2023130,305$148.0K<0.1%00.0%UnchangedHolders
Q4 2022130,305$117.0K<0.1%00.0%UnchangedHolders
Q3 2022130,305$152.0K<0.1%+130,305NewHolders
Q2 20220$00.0%−130,305−100.0%Sold outHolders
Q1 2022130,305$340.0K<0.1%+1,500+1.2%AddedHolders
Q4 2021128,805$501.0K<0.1%+2,000+1.6%AddedHolders
Q3 2021126,805$553.0K<0.1%00.0%UnchangedHolders
Q2 2021126,805$504.0K<0.1%+58,188+84.8%AddedHolders
Q1 202168,617$357.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.